Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients. Guerrera G, Mandelli A, Finardi A, Orrico M, et al. Mult Scler 2022 Jun 20:13524585221102158. doi: 10.1177/13524585221102158.

Read + Share

Amedeo Smart

Independent Medical Education

Guerrera G, Mandelli A, Finardi A, Orrico M, et al. Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients. Mult Scler 2022 Jun 20:13524585221102158. doi: 10.1177/13524585221102158.
PMID: 35723265